IDH1 and neoplasm: Previously reported Histone H3 lysine 27 acetylation (H3K27) ChIP-sequencing (ChIP-seq) data of an IDH-mutant cell line and tumor tissue also showed peaks associated with an active promoter region around the transcription start site of MKNL1, but not around that of MET (Fig. 6b).